![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Teva Nabs Allergan’s Generics Distributor for $500M
Teva Nabs Allergan’s Generics Distributor for $500M
Less than 24 hours after finalizing its acquisition of Allergan’s generics division, Teva Pharmaceutical disclosed plans to pick up the company’s distribution arm for $500 million.
The transaction is for Amgen’s Anda division, which has played a supporting role in launching both brand-name products and generics.
The deal, which Allergan described as a “strategic” purchase, is expected to close before the end of the year.
Upcoming Events
-
21Oct